Drawing for BUBBLEGEN

USPTO serial 79456188

BUBBLEGEN

Reviewed by CopyMark Law Group

Status 640Office Action
Filing date
Status date
Registration date
—
Examiner
HOPKINS, SARAH COLLEEN
Law office
TMO LAW OFFICE 123

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 640: Status 640 means the examining attorney has prepared a non-final Office Action but it has not been mailed or e-mailed yet. The action should appear in TSDR soon, and a response deadline will start once it is issued.

Need help with BUBBLEGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Reagents for scientific and medical research use; antibodies for scientific and medical research use; microbubbles used in cell selection, cell activation, gene editing and liquid biopsy, for scientific and medical research use; kits consisting of reagents, microbubbles and ligands, namely antibodies, nanobodies, buffers, aptamers and peptides, used in cell selection, cell activation, gene editing and liquid biopsy for scientific and medical research use.ACTIVE—
005Reagents for medical use; antibodies for medical use; microbubbles used in cell selection, cell activation, gene editing, and liquid biopsy for medical use; kits consisting of reagents, microbubbles, and ligands, namely antibodies, nanobodies, buffers, aptamers and peptides, used in cell selection, cell activation, gene editing and liquid biopsy for medical use.ACTIVE—
009Apparatus for separating, activating, isolating, preparing, collecting, expanding and cultivating cells, for gene editing and liquid biopsy, for laboratory and scientific use; cell separators for laboratory use; cell sorters for laboratory use; cell analyzers, not for medical purposes; bioreactors for cell culturing and expansion for scientific use; devices for microbubble suspension preparation for laboratory and scientific use and relevant components and accessories, namely tubing, adapters and spikes.ACTIVE—
010Apparatus for separating, activating, isolating, preparing, collecting, expanding and cultivating cells, for gene editing and liquid biopsy, for medical use and clinical use; cell separators for medical use; cell sorters for medical use; cell analyzers for medical purposes; bioreactors for cell culturing and expansion for medical and clinical use; devices for microbubble suspension preparation for medical and clinical use and relevant components and accessories, namely tubing, adapters and spikes.ACTIVE—
041Medical training and teaching in the fields of cell therapy, cell selection, cell activation, gene editing and liquid biopsy for medical research and medical use; training and teaching in the fields of cell therapy, cell selection, cell activation, gene editing and liquid biopsy for scientific use; arranging and conducting of conferences, congresses, workshops and webinars in the fields of cell therapy, cell selection, cell activation, gene editing and liquid biopsy for medical research and medical use; arranging and conducting of conferences, congresses, workshops and webinars in the fields of cell therapy, cell selection, cell activation, gene editing and liquid biopsy for scientific use.ACTIVE—
042Medical and scientific research in relation to cell therapy, cell selection, cell activation, gene editing and liquid biopsy; medical and scientific research in relation to cell selection, cell activation, gene editing and liquid biopsy for use in cell therapy; medical and scientific research in relation to cell therapy; providing medical and scientific research information in relation to cell therapy, cell selection, cell activation, gene editing and liquid biopsy; providing medical and scientific research information in relation to cell therapy, cell selection, cell activation, gene editing and liquid biopsy for use in cell therapy; providing medical and scientific research information in relation to cell therapy.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 15, 2026CHLDCHANGE OF OWNER RECEIVED FROM IB—
Oct 8, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 7, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2026DOCKASSIGNED TO EXAMINER—
Aug 16, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 16, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 13, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance